NCT03306680View on ClinicalTrials.gov

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

April 19, 2021

Study Completion Date

September 30, 2026

Conditions
Non Small Cell Lung Cancer
Interventions
RADIATION

SBRT

Patients will be assigned to treatment doses using the TITE-CRM model.

Trial Locations (7)

V8R 6V5

BC Cancer -Vancouver Island, Vancouver

N6A 4L6

London Regional Cancer Program, London

M4N 3M5

Sunnybrook Odette Cancer Centre, Toronto

M5G 1X6

Princess Margaret Cancer Centre, Toronto

H2X 0A9

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal

H4A 3J1

McGill University Health Centre-Cedars Cancer Centre, Montreal

S7S 0B1

Saskatoon Cancer Centre, Saskatoon

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER